Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
DE000A2P4LJ5
Thu, 27.06.2024
PharmaSGP Holding SE
PharmaSGP Holding SE: Annual General Meeting approves full distribution of the Group’s profit for 2023 following a successful business performance
89.74% of the share capital was represented; all agenda items were approved
Shareholders approve increased dividend distribution of €1.36 per dividend-bearing share
The appointment of Peter Gerckens [ … ]
Tue, 14.05.2024
PharmaSGP Holding SE
PharmaSGP continues dynamic business development with significant revenues growth in Q1 2024
Gräfelfing, May 14, 2024 – German OTC pharmaceutical company PharmaSGP Holding SE continued the positive business development of 2023 in the first quarter of 2024 and achieved an increase in revenues of 25.6% to €30.1 million (prior-year quarter: €24.0 mil [ … ]
Tue, 16.04.2024
PharmaSGP Holding SE
PharmaSGP exceeds the € 100 million revenues mark in 2023 and plans further profitable growth in 2024
Gräfelfing, April 16, 2024 – German OTC pharmaceutical company PharmaSGP Holding SE continued the successful development of previous years in the 2023 financial year and exceeded the € 100 million revenues mark for the first time in the company's [ … ]
Tue, 14.11.2023
PharmaSGP Holding SE
PharmaSGP continues the profitable growth course of the previous quarters in the third quarter of 2023
Gräfelfing, November 14, 2023 – German OTC pharmaceutical company PharmaSGP Holding SE continued the positive business development of the previous quarters in the third quarter of 2023. Based on preliminary, unaudited figures, quarterly revenues [ … ]
Thu, 14.09.2023
PharmaSGP Holding SE
PharmaSGP achieves top performance in the first half of 2023
Gräfelfing, September 14, 2023 – In the first half of 2023, German OTC pharmaceutical company PharmaSGP Holding SE continued its dynamic performance of the previous quarters, achieving half-year revenues of € 49.7 million based on preliminary, unaudited results. This corresponds to an i [ … ]
Thu, 29.06.2023
PharmaSGP Holding SE
PharmaSGP Holding SE: Strong support at 2023 AGM for very successful business development
91.11% of share capital represented; all agenda items approved
Shareholders approve dividend distribution of EUR 0.49 per dividend-bearing share
In 2022, PharmaSGP had again achieved record revenues with significant increase in profitability
After strong y [ … ]
Thu, 29.06.2023
PharmaSGP Holding SE
PharmaSGP Holding SE: Strong support at 2023 AGM for very successful business development
91.11% of share capital represented; all agenda items approved
Shareholders approve dividend distribution of EUR 0.49 per dividend-bearing share
In 2022, PharmaSGP had again achieved record revenues with significant increase in profitability
After strong y [ … ]
Wed, 10.05.2023
PharmaSGP Holding SE
PharmaSGP with a significant leap in revenue in Q1 2023 – EBITDA grows by more than 40%
Gräfelfing, 10 May 2023 – In the first quarter of 2023, German OTC pharmaceutical company PharmaSGP Holding SE continued its dynamic performance of the previous quarters and achieved the highest level of quarterly revenue in the company’s history to date at € 2 [ … ]
Wed, 10.05.2023
PharmaSGP Holding SE
PharmaSGP with a significant leap in revenue in Q1 2023 – EBITDA grows by more than 40%
Gräfelfing, 10 May 2023 – In the first quarter of 2023, German OTC pharmaceutical company PharmaSGP Holding SE continued its dynamic performance of the previous quarters and achieved the highest level of quarterly revenue in the company’s history to date at € 2 [ … ]
Wed, 19.04.2023
PharmaSGP Holding SE
PharmaSGP plans dividend distribution of 49.2% after record year in 2022
Gräfelfing, 19 April 2023 – The German OTC pharmaceutical company, PharmaSGP Holding SE (WKN A2P4LJ), remains on track for highly profitable growth. The Munich-based company posted the best set of figures in its history in financial year 2022, generating revenue of € 85.8 [ … ]